Product Images Mycophenolic Acid

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Mycophenolic Acid NDC 72322-1049 by Amta Labs Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

180 mg, 1000 tablets - 180mg 1000ct

180 mg, 1000 tablets - 180mg 1000ct

NDC 72322-1048-2 is a medication containing Mycophenolic Acid in Delayed-Release Tablets form. Each tablet contains mycophenolate sodium USP equivalent to 180 mg mycophenolic acid. The usual dosage and storage instructions can be found in the package insert. The medication should be protected from moisture and dispensed in a tight, light-resistant container with a child-resistant closure. Amta Labs Limited, in Coral Springs, Florida, 33076, distributes the medication, which is manufactured at Yichang Humanwell Oral Solid Dosage Plant, Yichang, Hubei, China 443112. A pharmacist is advised to dispense the accompanying Medication Guide to each patient.*

180 mg, 120 tablets - 180mg 120ct

180 mg, 120 tablets - 180mg 120ct

This is a medication package containing delayed-release tablets of mycophenolate, with each tablet having 180 mg of mycophenolic acid, which is stated in USP. The package is child-resistant and should be stored in a cool, dry place. The usual dosage is mentioned in the package insert. The pharmacist should dispense the medication guide to each patient, and the drugs should be kept away from the children. The manufacturer is Yichang Humanwell Oral Solid Dosage Plant in Hubei, China, while the distributor is Amta Labs Limited in Coral Spring, Florida, RX only. Serialization Area is also mentioned on the package.*

360 mg, 1000 tablets - 360mg 1000ct

360 mg, 1000 tablets - 360mg 1000ct

This is a medication called Mycophenolic Acid Delayed-Release Tablets, USP. Each delayed-release tablet contains mycophenolate sodium equivalent to 360 mg mycophenolic acid USP. It is recommended to store it at 20° to 25°C (68° to 77°F). This medication should only be dispensed to patients with a prescription, and the accompanying medication guide should be given to them. It should be kept in a tight, light-resistant container as defined in the USP with a child-resistant closure. This medication is distributed in Coral Spring, Florida, by Amta Labs Limited, and is manufactured in Yichang, Hubei, China, by Yichang Humanwell Oral Solid Dosage Plant.*

360 mg, 120 tablets - 360mg 120ct

360 mg, 120 tablets - 360mg 120ct

This is a medication package of delayed-release tablets containing mycophenolate sodium USP, which is equivalent to 360mg of mycophenolic acid. There is a recommended dosage provided in the package insert. The container is child-resistant and should be stored in a cool, dry place. The tablets should be protected from moisture and dispensed in a light-resistant container with a child-resistant closure. The drug has been manufactured in China and distributed by Amta Labs Limited. It is important to keep this and all drugs out of reach of children. A medication guide is provided for each patient.*

structure - chemical structure

structure - chemical structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.